BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18222156)

  • 1. Universal hepatitis B vaccination.
    Kretzschmar M; de Wit A
    Lancet Infect Dis; 2008 Feb; 8(2):85-7; author reply 90. PubMed ID: 18222156
    [No Abstract]   [Full Text] [Related]  

  • 2. Universal hepatitis B vaccination.
    Hahné S; Ramsay M; Coutinho R
    Lancet Infect Dis; 2008 Feb; 8(2):87-8; author reply 90. PubMed ID: 18222157
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal hepatitis B vaccination.
    Piazza M
    Lancet Infect Dis; 2008 Feb; 8(2):88-9; author reply 90. PubMed ID: 18222158
    [No Abstract]   [Full Text] [Related]  

  • 4. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
    Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
    Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
    Zuckerman J; van Hattum J; Cafferkey M; Gjørup I; Hoel T; Rummukainen ML; Weiland O
    Lancet Infect Dis; 2007 Jun; 7(6):410-9. PubMed ID: 17521594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [National hepatitis B vaccination closer to implementation, but not soon enough: recommendations from the Dutch Health Council].
    Gunning-Schepers LJ; Houweling H
    Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1572-3. PubMed ID: 11525094
    [No Abstract]   [Full Text] [Related]  

  • 7. Denmark decides not to introduce hepatitis B into the childhood vaccination programme.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.3. PubMed ID: 16794274
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment.
    Hontelez JA; Hahné S; Koedijk FH; de Melker HE
    J Epidemiol Community Health; 2010 Oct; 64(10):890-4. PubMed ID: 19822551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 10. [National hepatitis B vaccination closer to implementation, but not soon enough; recommendations from the Dutch Health Council].
    Galama JM
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1339-42. PubMed ID: 11484429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denmark scales up hepatitis B screening and vaccination for risk groups.
    Cowan SA
    Euro Surveill; 2005 Nov; 10(11):E051103.4. PubMed ID: 16794275
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination against hepatitis B in low endemic countries.
    Kretzschmar M; de Wit GA; Smits LJ; van de Laar MJ
    Epidemiol Infect; 2002 Apr; 128(2):229-44. PubMed ID: 12002541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why should Australia adopt universal infant hepatitis B vaccination?
    Thompson SC; Oman K
    Aust N Z J Public Health; 1996 Aug; 20(4):436-9. PubMed ID: 8908772
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward.
    Qureshi H
    East Mediterr Health J; 2013 Jul; 19(7):585-6. PubMed ID: 24975300
    [No Abstract]   [Full Text] [Related]  

  • 15. A cohesive European policy for hepatitis B vaccination, are we there yet?
    Lernout T; Hendrickx G; Vorsters A; Mosina L; Emiroglu N; Van Damme P
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():19-24. PubMed ID: 24829936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The United Kingdom's hepatitis B immunisation strategy--where now?
    Goldberg D; McMenamin J
    Commun Dis Public Health; 1998 Jun; 1(2):79-83. PubMed ID: 9644118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparing for the next public debate: universal vaccination against hepatitis B.
    Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
    Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against hepatitis B and epidemiological situation of this disease in European countries in the years 1990-2001].
    Magdzik W
    Przegl Epidemiol; 2006; 60(2):179-84. PubMed ID: 16964667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should Europe have a universal hepatitis B vaccination programme?
    Van Damme P; Leuridan E; Hendrickx G; Vorsters A; Theeten H; Leino T; Salminen M; Kuusi M
    BMJ; 2013 Jul; 347():f4057. PubMed ID: 23843546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.